Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 21076021)

1.

Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.

Shahbaz AU, Zhao T, Zhao W, Johnson PL, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2011 Feb;300(2):H636-44. doi: 10.1152/ajpheart.00900.2010. Epub 2010 Nov 12.

2.

Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism.

Kamalov G, Ahokas RA, Zhao W, Zhao T, Shahbaz AU, Johnson PL, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2010 Mar;55(3):248-54. doi: 10.1097/FJC.0b013e3181cf0090.

3.

Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.

Kamalov G, Deshmukh PA, Baburyan NY, Gandhi MS, Johnson PL, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2009 May;53(5):414-23. doi: 10.1097/FJC.0b013e3181a15e77.

4.

Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism.

Kamalov G, Ahokas RA, Zhao W, Shahbaz AU, Bhattacharya SK, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H385-94. doi: 10.1152/ajpheart.00593.2009. Epub 2009 Nov 13.

5.

Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Borkowski BJ, Cheema Y, Shahbaz AU, Bhattacharya SK, Weber KT.

Eur Heart J. 2011 Aug;32(15):1846-53. doi: 10.1093/eurheartj/ehr063. Epub 2011 Mar 12.

6.

Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.

Gandhi MS, Deshmukh PA, Kamalov G, Zhao T, Zhao W, Whaley JT, Tichy JR, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2008 Sep;52(3):245-52. doi: 10.1097/FJC.0b013e3181833eb8.

7.

Mitochondria-targeted cardioprotection in aldosteronism.

Shahbaz AU, Kamalov G, Zhao W, Zhao T, Johnson PL, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2011 Jan;57(1):37-43. doi: 10.1097/FJC.0b013e3181fe1250.

8.

Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol.

Cheema Y, Sherrod JN, Zhao W, Zhao T, Ahokas RA, Sun Y, Gerling IC, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2011 Jul;58(1):80-6. doi: 10.1097/FJC.0b013e31821cd83c.

9.

Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone.

Thomas M, Vidal A, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2361-6. Epub 2007 Jul 6.

10.

Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Yusuf J, Khan MU, Cheema Y, Bhattacharya SK, Weber KT.

Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):77-86. doi: 10.1016/j.pcad.2012.02.004. Review.

11.

Stressor states and the cation crossroads.

Weber KT, Bhattacharya SK, Newman KP, Soberman JE, Ramanathan KB, McGee JE, Malik KU, Hickerson WL.

J Am Coll Nutr. 2010 Dec;29(6):563-74. Review.

PMID:
21677120
12.

Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.

Townsend PA, Davidson SM, Clarke SJ, Khaliulin I, Carroll CJ, Scarabelli TM, Knight RA, Stephanou A, Latchman DS, Halestrap AP.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H928-38. Epub 2007 May 4.

13.

Congestive heart failure: where homeostasis begets dyshomeostasis.

Kamalov G, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2010 Sep;56(3):320-8. doi: 10.1097/FJC.0b013e3181ed064f.

14.

From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.

Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT.

Hypertens Res. 2010 Nov;33(11):1091-101. doi: 10.1038/hr.2010.159. Epub 2010 Sep 9. Review.

PMID:
20827279
15.

Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.

Wang R, Miura T, Harada N, Kametani R, Shibuya M, Fukagawa Y, Kawamura S, Ikeda Y, Hara M, Matsuzaki M.

J Pharmacol Exp Ther. 2006 Jul;318(1):45-52. Epub 2006 Apr 12.

16.

Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.

Oliveira PJ, Bjork JA, Santos MS, Leino RL, Froberg MK, Moreno AJ, Wallace KB.

Toxicol Appl Pharmacol. 2004 Oct 15;200(2):159-68.

PMID:
15476868
17.

An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model.

Ishizawa M, Mizushige K, Noma T, Namba T, Guo P, Murakami K, Tsuji T, Miyatake A, Ohmori K, Kohno M.

Life Sci. 2006 May 15;78(25):2974-82. Epub 2006 Mar 31.

PMID:
16580698
18.

Mitochondrial disruption occurs downstream from β-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways.

Branco AF, Sampaio SF, Wieckowski MR, Sardão VA, Oliveira PJ.

Int J Biochem Cell Biol. 2013 Nov;45(11):2379-91. doi: 10.1016/j.biocel.2013.08.006. Epub 2013 Aug 16.

PMID:
23958426
19.

Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.

Ruiz-Meana M, Abellán A, Miró-Casas E, Garcia-Dorado D.

Basic Res Cardiol. 2007 Nov;102(6):542-52. Epub 2007 Sep 24.

PMID:
17891523
20.

Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease.

Khan MU, Zhao W, Zhao T, Al Darazi F, Ahokas RA, Sun Y, Bhattacharya SK, Gerling IC, Weber KT.

J Cardiovasc Pharmacol. 2013 Nov;62(5):445-51. doi: 10.1097/FJC.0b013e3182a0b5ff.

PMID:
23921314
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk